0001209191-21-011401.txt : 20210217
0001209191-21-011401.hdr.sgml : 20210217
20210217174058
ACCESSION NUMBER: 0001209191-21-011401
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210215
FILED AS OF DATE: 20210217
DATE AS OF CHANGE: 20210217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kopczynski Casey C.
CENTRAL INDEX KEY: 0001590001
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 21646467
MAIL ADDRESS:
STREET 1: 135 U.S. HIGHWAY 206
STREET 2: SUITE 15
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001337553
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203109565
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4301 EMPEROR BOULEVARD
STREET 2: SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: (919) 237-5300
MAIL ADDRESS:
STREET 1: 4301 EMPEROR BOULEVARD
STREET 2: SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-15
0
0001337553
AERIE PHARMACEUTICALS INC
AERI
0001590001
Kopczynski Casey C.
C/O AERIE PHARMACEUTICALS, INC.
4301 EMPEROR BLVD., SUITE 400
DURHAM
NC
27703
0
1
0
0
Chief Scientific Officer
Common Stock
2021-02-15
4
M
0
60651
0.196
A
265522
D
Common Stock
2021-02-15
4
F
0
725
16.41
D
264797
D
Stock Option (right to buy)
0.196
2021-02-15
4
M
0
60651
0.00
D
2021-04-28
Common Stock
60651
0
D
This option is fully vested and exercisable. If not exercised, the option would have expired on April 28, 2021.
/s/ John LaRocca, Attorney-in-Fact for Casey C. Kopczynski
2021-02-17